🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Italy / NCT04905264
Recruiting Observational

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

NCT04905264 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2022-01-03
Last updated
2025-08-13

Condition(s) studied

Brain Injuries, Acute

Study summary

The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact.

The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients with Serious Acquired Brain Injuries * admission to rehabilitation units Exclusion Criteria: \- patients admitted more than 14 weeks after the acute event

Primary outcome measure(s)

Trial sites (27)

FacilityCityRegionStatus
Ospedale SS. Antonio e Biagio e C. Arrigo Alessandria Italy Recruiting
Centro di Riabilitazione Terranuova Bracciolini Arezzo Italy Recruiting
Ospedale civile di Baggiovara Baggiovara Italy Recruiting
ASST Papa Giovanni XXIII Bergamo Italy Recruiting
Ospedale Maggiore Bologna Italy Recruiting
Fondazione Poliambulanza Brescia Italy Recruiting
Ospedale S. Michele, AO Brotzu Cagliari Italy Active Not Recruiting
Ospedale S. Sebastiano Correggio Italy Recruiting
Istituto S. Anna Crotone Italy Recruiting
Azienda Ospedaliero-Universitaria di Ferrara Ferrara Italy Recruiting
Fondazione Don Gnocchi Florence Italy Recruiting
Ospedale di Foligno Foligno Italy Not Yet Recruiting
Montecatone Rehabilitation Institute SpA Imola Italy Recruiting
USL Toscana Nord Ovest Lucca Italy Recruiting
IRCCS S. Maria Nascente, Fondazione don Gnocchi Milan Italy Recruiting
Istituto Palazzolo, Don Gnocchi Milan Italy Not Yet Recruiting
Ospedale Sacro Cuore don Calabria Negrar Italy Recruiting
ATS Sardegna Oristano Italy Not Yet Recruiting
Ospedale Buccheri La Ferla Fatebenefratelli Palermo Italy Not Yet Recruiting
Centro Cardinal Ferrari Parma Italy Not Yet Recruiting
AUSL Piacenza Piacenza Italy Recruiting
Centro di riabilitazione E. Spalenza, Don Gnocchi Rovato Italy Recruiting
Ospedale "Casa Sollievo della Sofferenza" San Giovanni Rotondo Italy Recruiting
Fondazione Don Gnocchi, Sant'Angelo dei Lombardi Sant'Angelo dei Lombardi Italy Recruiting
IRCCS Telese, ICS Maugeri Telese Terme Italy Not Yet Recruiting
Ospedale Riabilitativo Villa Rosa Trento Italy Recruiting
A.ULSS n.8 Berica Vicenza Italy Recruiting

More Mario Negri Institute for Pharmacological Research trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04905264 on ClinicalTrials.gov ↗ ← All trials in Italy